2010•China Medical HeraldRequires access

Clinical observation of Azithromycin combined with Ceftazidime in the treatment of community acquired pneumonia

Qinghong Wu

Open publisher page 0 citations

Abstract

Objective: To explore the efficacy of Azithromycin combined with Ceftazidime in the treatment of community acquired pneumonia.Methods: 61 patients with community acquired pneumonia in our hospital were randomly divided into two groups,31 cases of observation group were treated by Azithromycin combined with Ceftazidime,30 cases of control group were treated by and Erythromycin combined with Ceftazidime,the efficacy of two groups were observed.Results: The total effective rate of observation group was 96.8%,significantly higher than 76.7% of control group,there was statistically significant difference between two groups(P0.05);there were no significant adverse reaction between two groups.Conclusion: Azithromycin combined with Ceftazidime in the treatment of community acquired pneumonia has satisfactory curative effect and no significant adverse reaction,it is worth spreading.

About this research paper

What this paper is about

Objective: To explore the efficacy of Azithromycin combined with Ceftazidime in the treatment of community acquired pneumonia.Methods: 61 patients with community acquired pneumonia in our hospital were randomly divided into two groups,31 cases of observation group were treated by Azithromycin combined with Ceftazidime,30 cases of control group were treated by and Erythromycin combined with Ceftazidime,the efficacy of two groups were observed.Results: The total effective rate of observation group was 96.8%,significantly higher than 76.7% of control group,there was statistically significant difference between two groups(P0.05);there were no significant adverse reaction between two groups.Conclusion: Azithromycin combined with Ceftazidime in the treatment of community acquired pneumonia has satisfactory curative effect and no significant adverse reaction,it is worth spreading.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore the efficacy of Azithromycin combined with Ceftazidime in the treatment of community acquired pneumonia.Methods: 61 patients with community acquired pneumonia in our hospital were randomly divided into two groups,31 cases of observation group were treated by Azithromycin combined with Ceftazidime,30 cases of control group were treated by and Erythromycin combined with Ceftazidime,the efficacy of two groups were observed.Results: The total effective rate of observation group was 96.8%,significantly higher than 76.7% of control group,there was statistically significant difference between two groups(P0.05);there were no significant adverse reaction between two groups.Conclusion: Azithromycin combined with Ceftazidime in the treatment of community acquired pneumonia has satisfactory curative effect and no significant adverse reaction,it is worth spreading.

Key concepts: Ceftazidime, Medicine, Azithromycin, Community-acquired pneumonia, Pneumonia, Erythromycin, Internal medicine, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of Azithromycin combined with Ceftazidime in the treatment of community acquired pneumonia — Research Paper | ScholarLens